Tabitha M. Powledge reports on coverage of what may be a milestone in the use of CRISPR gene editing to delete dozens of genes at once from pig embryos. That work, from the Harvard Medical School lab of George Church, might point toward new sources of organs for transplant, Powledge writes: "In short, Church & Co. seem to be making progress also in creating pig organs that human immune systems won’t reject." It remains to be seen whether the promise becomes reality.
October 17, 2015
.png)
